A Chaperome Sub-Network Safeguards Proteostasis in Aging and Neurodegenerative Disease

Chaperones are central to the proteostasis network (PN) and safeguard the proteome from misfolding, aggregation and proteotoxicity. We categorized the human chaperome of 332 genes into network communities using function, localization, interactome, and expression datasets. During human brain aging, e...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 9; no. 3; pp. 1135 - 1150
Main Authors Brehme, Marc, Voisine, Cindy, Rolland, Thomas, Wachi, Shinichiro, Soper, James H, Zhu, Yitan, Orton, Kai, Villella, Adriana, Garza, Dan, Vidal, Marc, Ge, Hui, Morimoto, Richard I
Format Journal Article
LanguageEnglish
Published 23.10.2014
Online AccessGet full text

Cover

Loading…
More Information
Summary:Chaperones are central to the proteostasis network (PN) and safeguard the proteome from misfolding, aggregation and proteotoxicity. We categorized the human chaperome of 332 genes into network communities using function, localization, interactome, and expression datasets. During human brain aging, expression of 32% of the chaperome corresponding to ATP-dependent chaperone machines is repressed, whereas 19.5% corresponding to ATP-independent chaperones and co-chaperones are induced. These repression and induction clusters are enhanced in Alzheimer's, Huntington's, and Parkinson's brains. Functional properties of the chaperome were assessed by perturbation in C. elegans and human cell models expressing Aβ, polyglutamine and Huntingtin. Of 219 C. elegans orthologs, knockdown of sixteen enhanced both Aβ and polyQ-associated toxicity. These correspond to 28 human orthologs, of which 52% and 41% are repressed, respectively, in brain aging and disease, and 37.5% affected Huntingtin aggregation in human cells. These results identify a critical chaperome sub-network that functions in aging and disease.
Bibliography:Current address: Department of Biology, Northeastern Illinois University, Chicago IL 60625, USA
Current address: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria
ISSN:2211-1247
DOI:10.1016/j.celrep.2014.09.042